Bioequivalence Study of Pimavanserin 34 mg Capsule
Trial
Phase 1
Completed
June 9, 2024
Single-center Study of Gustation in Idiopathic Parkinson's Disease and Lewy Body Disease Using Gustatory Evoked Potential Analysis
Trial
N/A
Recruiting
June 6, 2024
Phase II Clinical Study of TR-012001 in Japanese Patients With Parkinson's Disease
Trial
Phase 2
Completed
June 5, 2024
Oral Therapeutic Education in Stimulated Parkinsonian Patients
Trial
N/A
Terminated
June 5, 2024
Evaluation of a Decision Aid for Deep Brain Stimulation Surgery for Parkinson's Disease
Trial
N/A
Recruiting
June 5, 2024
Golf, Physical Rehabilitation, and Movement Disorders
Trial
N/A
Completed
June 5, 2024
Effects of Table Tennis for People With Parkinson's Disease
Trial
N/A
Recruiting
June 4, 2024
Short-Term Effect Of Ceriter Stride One (CSO) on FOG and Falling in pwP
Trial
N/A
Completed
June 4, 2024
Local Fields Potentientals of the Subthalamic Nucleus in Patients With Parkinson's Disease
Trial
N/A
Unknown
June 2, 2024
Retrospective, Non-significant Risk, Deep Brain Stimulation (DBS) Care Management Software Feasibility Study
Trial
N/A
Completed
June 2, 2024
Intravenous Plasma Treatment for Parkinson's Disease
Trial
Early Phase 1
Completed
May 30, 2024
Extended-Release Melatonin in Patients With Rapid Eye Movement Sleep Behavior Disorder
Trial
N/A
Terminated
May 28, 2024
Clinical Study on the Efficacy of Natural Stem Cell Mobilizers on Parkinson Disease
Trial
N/A
Unknown
May 28, 2024
Estimates of the Short-term Efficacy of Talineuren (TLN) and Placebo in Patients With Parkinson Disease
Trial
Phase 2
Unknown
May 28, 2024
Multimodal Neuromodulation in Individuals With Parkinson's Disease
Trial
N/A
Completed
May 28, 2024
Useability and Acceptability of the CUE1 Device in Older People With Parkinson's Disease
Trial
N/A
Unknown
May 27, 2024
Personalizing Exercise for Parkinson Disease
Trial
N/A
Unknown
May 27, 2024
Effects of Cycling Dual-task in Parkinson's Disease.
Trial
N/A
Completed
May 23, 2024
Telerehabilitation for Dysautonomia in Parkinson's Disease
Trial
N/A
Completed
May 22, 2024
Validation of Bulbicam for Parkinson- and Ataxia-patients
Trial
N/A
Completed
May 21, 2024